Survival in dogs with dilated cardiomyopathy and congestive heart failure treated with digoxin, furosemide and propranolol: A retrospective study of 62 dogs

Journal of Veterinary Cardiology

Volumn 8, Issue 1, 2006, Pages 41-47

  Tidholm, Anna ^a  

^a AniCura Albano Animal Hospital and AniCura Gärdets Animal Clinic   (Sweden)

Author keywords

Blocker therapy; Conventional therapy in congestive heart failure; DCM; Survival analysis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; ENALAPRIL; FUROSEMIDE; LEVOTHYROXINE; PROPRANOLOL; SPIRONOLACTONE;

ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DOG DISEASE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG TOLERABILITY; EUTHANASIA; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART VENTRICLE EXTRASYSTOLE; HYPOTHYROIDISM; KAPLAN MEIER METHOD; LUNG EDEMA; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33744933463     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2006.01.003     Document Type: Article

References (34)

1. Borgarelli M., Tarducci A., Tidholm A., et al. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy. Vet J 162 (2001) 182-185
2. Sisson D., O'Grady M.R., and Calvert C.A. Myocardial diseases of dogs. In: Fox P.R., Sisson D., and Moise N.S. (Eds). Textbook of canine and feline cardiology: principles and clinical practice (1999), WB Saunders, Philadelphia 581-619
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality of severe congestive heart failure: results of the cooperative North Scandinavia survival study. N Engl J Med 316 (1987) 1429-1435
4. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
5. Ettinger S.J., Benitz A.M., Ericsson G.F., et al. Effects of enalapril maleate on survival of dogs with naturally occurring acquired heart failure. J Am Vet Med Assoc 213 (1998) 1573-1577
6. The Bench (Benazepril in canine heart disease) study group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled long-term clinical trial. J Vet Cardiol 1 (1999) 7-17
7. Muir W.W. Clinical pharmacodynamics and pharmacokinetics of beta-adrenoceptor blocking drugs in veterinary medicine. Comp Cont Educ 6 (1984) 156-166
8. Bristow M.R., Kantrowitz N.E., Ginsburg R., et al. Beta-adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 17 (1985) 41-52
9. Bristow M.R. Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol 71 (1993) 12C-22C
10. Tidholm A., Häggström J., and Hanson K. Effects of dilated cardiomyopathy on vasopressin, cortisol and catecholamine concentrations in dogs. Am J Vet Res 66 (2005) 1709-1717
11. Bristow M.R. β-Adrenergic receptor blockade in chronic heart failure. Circulation 101 (2000) 692-713
12. Mann D.L. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100 (1999) 999-1008
13. Bristow M.R., Ginsburg R., Fowler M., et al. β1 And β2 adrenergic receptor subpopulations in normal and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1 receptor down-regulation in heart failure. Circ Res 59 (1986) 297-309
14. Muir W.W., Sams R.A., and Moise S.N. Pharmacology and pharmacokinetics of antiarrhythmic drugs. In: Fox P.R., Sisson D., and Moise S.N. (Eds). Canine and feline cardiology. Principles and clinical practice (1999), Saunders WB, Philadelphia 307-330
15. Waagstein F., Hjalmarson A., Varnauskas E., et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37 (1975) 1022-1036
16. Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patient with congestive heart failure. Circulation 73 (1986) 503-510
17. Waagstein F., Bristow M.R., Swedberg K., et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342 (1993) 1441-1446
18. The Cibis investigators and committees. A randomized trial of β-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). Circulation 90 (1994) 1765-1773
19. Heidenreich P.A., Lee T.T., and Massie B.M. Effects of beta blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 30 (1997) 27-34
20. Rush J.E., Freeman L.M., Hiler C., et al. Use of metoprolol in dogs with acquired cardiac disease. J Vet Cardiol 4 (2002) 23-27
21. Moise N. Ecocardiography. In: Fox P.R. (Ed). Canine and feline cardiology (1988), Churchill and Livingstone, New York 113-156
22. Sahn D.J., De Maria A., Kisslo J., et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
23. Thomas W.P., Gaber C.E., Jacobs G.J., et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 7 (1993) 247-252
24. Kienle R.D. Echocardiography. In: Kittleson M.D., and Kienle R.D. (Eds). Small animal cardiovascular medicine (1998), The CV Mosby Co, St. Louis 104
25. Tilley L.P. Essentials of canine and feline electrocardiography. 2nd ed. (1985), Lea & Febiger, Philadelphia p. 58-75
26. Petrie A., and Watson P. Statistics for veterinary and animal science (1999), Blackwell Science, Oxford
27. Chatterjee K. Potential use of third-generation β-blockers in heart failure. J Cardiovasc Pharmacol 14 (1989) S22-S27
28. MERITHF. Effects of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
29. Tidholm A., Falk T., Gundler S., et al. Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial. Res Vet Sci 75 (2003) 195-201
30. Tidholm A., Svensson H., and Sylvén C. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy. J Am Anim Hosp Assoc 33 (1997) 364-368
31. Calvert C.A., Pickus C.W., Jacobs G.J., et al. Signalment, survival and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy. J Vet Intern Med 11 (1997) 323-326
32. Monnet E., Orton C., Salman M., et al. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators. J Vet Intern Med 9 (1995) 12-17
33. Tidholm A., and Jönsson L. Histologic characterization of canine dilated cardiomyopathy. Vet Pathol 42 (2005) 1-8
34. Doi M., Yano M., Kobayashi S., et al. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine. Circulation 105 (2002) 1374-1379